Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 5;17(5):1686.
doi: 10.3390/ijerph17051686.

Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine

Shih-Bin Su  1 , Hsiao-Liang Chang  2 , And Kow-Tong Chen  3   4
Affiliations
Review

Current Status of Mumps Virus Infection: Epidemiology, Pathogenesis, and Vaccine

Shih-Bin Su et al. Int J Environ Res Public Health. .

Abstract

Mumps is an important childhood infectious disease caused by mumps virus (MuV). We reviewed the epidemiology, pathogenesis, and vaccine development of mumps. Previous studies were identified using the key words "mumps" and "epidemiology", "pathogenesis" or "vaccine" in MEDLINE, PubMed, Embase, Web of Science, and Google Scholar. We excluded the articles that were not published in the English language, manuscripts without abstracts, and opinion articles from the review. The number of cases caused by MuV decreased steeply after the introduction of the mumps vaccine worldwide. In recent years, a global resurgence of mumps cases in developed countries and cases of aseptic meningitis caused by some mumps vaccine strains have renewed the importance of MuV infection worldwide. The performance of mumps vaccination has become an important issue for controlling mumps infections. Vaccine development and routine vaccination are still effective measures to globally reduce the incidence of mumps infections. During outbreaks, a third of MMR vaccine is recommended for groups of persons determined by public authorities.

Keywords: epidemiology; mumps; pathogenesis; vaccine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest exist.

Figures

Figure 1
Figure 1
Flow chart of article searching procedures.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hviid A., Rubin S., Muhlemann K. Mumps. Lancet. 2008;371:932–944. doi: 10.1016/S0140-6736(08)60419-5. - DOI - PubMed
    1. Betáková T., Svetlíková D., Gocník M. Overview of measles and mumps vaccine: Origin, present, and future of vaccine production. Acta Virol. 2013;57:91–96. doi: 10.4149/av_2013_02_91. - DOI - PubMed
    1. Rubin S., Kennedy R., Poland G. Emerging mumps infection. Pediatr. Infect. Dis. J. 2016;35:799–801. doi: 10.1097/INF.0000000000001182. - DOI - PubMed
    1. Wellington K., Goa K.L. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): A review of its use in the prevention of measles, mumps and rubella. Drugs. 2003;63:2107–2126. doi: 10.2165/00003495-200363190-00012. - DOI - PubMed
    1. Marlow M.A., Marin M., Moore K., Patel M. CDC guidance for use of a third dose of MMR vaccine during outbreaks. J. Public Health Manag. Pract. 2020;26:109–115. doi: 10.1097/PHH.0000000000000962. - DOI - PubMed

Publication types

Substances